Insider Trading: ARIAD Pharmaceuticals Inc (ARIA.O)

ARIA.O on Nasdaq

16.67USD
17 May 2013
Price Change (% chg)

$0.20 (+1.21%)
Prev Close
$16.47
Open
$16.66
Day's High
$16.85
Day's Low
$16.40
Volume
3,261,521
Avg. Vol
3,028,983
52-wk High
$25.40
52-wk Low
$15.13

Search Stocks
CLACKSON TIMOTHY P Options Exercised: 0
Trade Date: Tuesday, 1 May 2012 Price: 7.44
Title: Officer Shares Held: 233,778
Type Traded: Direct Net Change in Shares This Filing: 0
» More Insider Trading

Institutional Holders

% Shares Owned: 84.26%
# of Holders: 302
Total Shares Held: 155,624,343
3 Mo. Net Change: 20,671,964
# New Positions: 41
# Closed Positions: 24
# Increased Positions: 163
# Reduced Positions: 97
# Net Buyers: 66

Officers & Directors

Name Age Since Current Position

Harvey Berger

 62 2004 Chairman of the Board, President, Chief Executive Officer

Edward Fitzgerald

 57 2010 Chief Financial Officer, Executive Vice President, Treasurer

Raymond Keane

 53 2009 Senior Vice President, General Counsel, Secretary and Chief Compliance Officer

David Berstein

 60 2008 Senior Vice President, Chief Intellectual Property Officer

Daniel Bollag

 51 2009 Senior Vice President - Regulatory Affairs and Quality

Maria Cantor

 44 2012 Senior Vice President - Corporate Affairs

Pierre Dodion

 57 2012 Senior Vice President - Corporate Development and Operations

Martin Duvall

 50 2011 Senior Vice President - Commercial Operations

Frank Haluska

 53 2012 Senior Vice President - Clinical Research and Development and Chief Medical Officer

Timothy Clackson

 47 2010 President - Research and Development, Chief Scientific Officer

Athanase Lavidas

 64 2008 Lead Independent Director

Jay LaMarche

 65 2000 Independent Director

Massimo Radaelli

 54 2008 Independent Director

Norbert Riedel

 2011 Independent Director

Robert Whelan

 60 2010 Independent Director

Wayne Wilson

 63 2008 Independent Director
Search Stocks